KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 14 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $10,456,000 | -59.1% | 10,000,000 | -60.0% | 0.04% | -66.1% |
| Q1 2021 | $25,538,000 | -41.3% | 25,000,000 | -28.6% | 0.13% | -51.5% |
| Q4 2020 | $43,527,000 | -6.8% | 35,000,000 | -9.1% | 0.26% | -18.9% |
| Q3 2020 | $46,694,000 | -7.1% | 38,523,000 | +9.7% | 0.32% | -19.7% |
| Q2 2020 | $50,287,000 | +1.7% | 35,102,000 | 0.0% | 0.40% | -5.4% |
| Q1 2020 | $49,460,000 | +43.7% | 35,102,000 | +46.3% | 0.42% | +83.2% |
| Q4 2019 | $34,430,000 | – | 24,000,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 15,000,000 | $15,028,000 | 1.61% |
| Context Capital Management, LLC | 13,000 | $13,039,000 | 1.21% |
| STEELHEAD PARTNERS LLC | 14,000,000 | $13,941,000 | 0.92% |
| PenderFund Capital Management Ltd. | 3,000,000 | $3,754,000 | 0.88% |
| AQR Arbitrage LLC | 7,000,000 | $7,021,000 | 0.20% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 20,000,000 | $19,960,000 | 0.16% |
| CSS LLC/IL | 2,000,000 | $1,991,000 | 0.08% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,000,000 | $10,456,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 17,500,000 | $17,552,000 | 0.02% |
| Daiwa Securities Group Inc. | 3,000,000 | $3,004,000 | 0.02% |